In this increasingly competitive and evolving market, we commit ourselves to working cooperatively to provide the highest quality and most effective laboratory services to the benefit of our patients, providers, health care institutions, laboratories and communities. We dedicate ourselves to achieving these goals through sharing our expertise, creativity and leadership in the spirit of professional collegiality and consensus.

New CT and NG Dual target assay

 

Effective May 8, 2012:

The new Chlamydia trachomatis and Neisseria gonorrhoeae

Dual Target PCR assay will go live. 

See technical bulletin:

CT_NG_Dual_Target_ PCR_Assay_05_2012 for test details.



HCV Ribas unavailable as of 3/28/2012

Due to a nationwide reagent shortage, the HCV Riba assay is unavailable until further notice.

Note interpretation changes for the HCV Ab assay that previously required an HCV Riba.

Quest recommends Hepatitis C Viral RNA, Quantitative Real-Time PCR  (test code 35645) as an alternative assay for the HCV Riba.

See Quest website for specimen requirements.



Update to QFT Collection Instructions

The QFT Collection instructions have been updated.

Refer to the QFT Blood Collection Instruction_03_2012

found in the Technical Notes section.



Rheumatoid Factor Assay

Effective 2/15/2012: Rheumatoid factor specimens are temporatily being sent to Quest Diagnostics, Chantilly, Va.

The appropriate reference range is included in the report.



Folate Re-standardization effective 1/9/2012

The serum folate assay is standardized to the

World Health Organization (WHO) International

Standard 03/178. 

Note new reference range is >=6.0 ng/mL.

 

Based on comparison studies between the current

and restandardized folate assays, patient samples

will shift upward by approximately 30 to 45%.

 

The WHO Technical Consultation* on folate and

vitamin B12 deficiencies has determined that

deficient folate concentrations are considered  to

be less than 4 ng/mL.

* Food and Nutrition Bulletin.  The United Nations

University, 2008:29(2):S238 to 246.

 



HBsAB reference range change effective 12/30/2011

Effective 12/30/2011- The reference range for HBsAb Quantitative results has changed.

Results >= 12.0 mIU/mL are considered reactive

Indeterminate results are 8.0 to 11.9 mIU/mL

<8.0 mIU/mL are considered Non reactive

EDTA specimens are no longer acceptable for this test.

Technical bulletin to follow.

 



New technical bulletins posted

There are 2 new technical bulletins posted 11_08_2011:

BRAF Melanoma  Assay 

KRAS and BRAF Additional Information Requirement



ENA Testing referred to Quest Diagnostics

Effective 11/7/2011:  ENA testing will be referred to Quest Diagnostics Nichols Institute, Chantilly Va.

Specimens are stable 7 days refrigerated.

The method has changed to Immunoassay.






Central PA Alliance Laboratory
1803 Mount Rose Avenue
Suite C3 - C4
York, Pennsylvania 17403

Phone:  717-851-1416
888-480-1422
FAX:      717-851-1450

Contact Us

Email:   jwisotzkey@cpallab.com
Web:     www.cpallab.com

Copyright© 2012 Central Pennsylvania Alliance Laboratory
All Rights Reserved

Member Area